How much funding has Genapsys raised?

Genapsys has raised $205.5M in total funding, most recently a Series D round.

Who are Genapsys's investors?

Genapsys's investors include Decheng Capital, Farallon Capital, Foresite Capital, IPV Capital, Soleus Capital, Yuri Milner.

Where is Genapsys headquartered?

Genapsys is headquartered in San Francisco, California, United States.

What industry is Genapsys in?

Genapsys operates in Healthcare.

Genapsys

Closed

Transform the human condition by building a scalable, affordable genomic sequencing ecosystem

San Francisco, United States · Founded 2010 · $205.5M raised

Healthcare

Headquarters: San Francisco, California
Employees: 51–200
Founded: 2010
Business Model: B2B

Website: genapsys.com
Total Funding: $205.5M
Last Round: $70.0M Series DMay 2021
Rounds: 4

About

GenapSys developed a novel electronic DNA sequencing technology for applied genomic testing and medical sequencing. Founded at Stanford, the company built a portable sequencer using electronic detection rather than optical methods. GenapSys raised $249M before filing for Chapter 11 bankruptcy in 2023 and shutting down operations.

Summary

Genapsys is a Healthcare company based in San Francisco, United States, founded in 2010. It has raised $205.5M in total across 4 rounds, most recently a $70.0M Series D round in May 2021. Investors include Decheng Capital, Farallon Capital and Foresite Capital.

LinkedIn X (Twitter)GitHub